Media Coverage

Anne B. Curtis, MD, SUNY Distinguished Professor and Charles and Mary Bauer Professor and chair of the Department of Medicine, discussed new technologies embedded in watches and other wearables shown at the annual Consumer Electronics Show. “I’ve made diagnoses on patients by looking at these [recordings] a few days later,” she said. “All you have to do is have the symptoms last long enough for a patient to turn on an app and make a 30-second recording.”
New research by Steven Lipshultz, MD, A. Conger Goodyear Professor and chair of the Department of Pediatrics, showed that exposure to a common drug for attention deficit hyperactivity disorder isn’t likely to increase cardiovascular risk in healthy children, according to a new study involving primates. “The findings are very reassuring in that even high-dose chronic MPH stimulant therapy did not result in any evidence of abnormal structures or function in the hearts of the monkeys,” he said.
John J. Leddy, MD, clinical professor of orthopaedics and director of the UB’s Concussion Management Clinic, is quoted in several articles about EyeBOX, a noninvasive tool created to help in the diagnosis of concussion. Leddy said the device could offer a solution by providing researchers with an objective oculomotor assessment tool.
A front-page article about a South Buffalo family with seven children, including a set of twins, and is now expecting triplets interviews Paul Ogburn, MD, clinical professor of obstetrics and gynecology, about how unusual it is for a woman to give birth to twins and then triplets. "It's certainly not highly likely, but if there's a tendency to have multiple ovulations, it may be more likely for someone who's had twins to have triplets," he said.
Dori R. Marshall, MD ’97, associate dean and director of medical admissions and assistant professor in the Department of Psychiatry, is interviewed in an article about the expansion of a medical school in Elmira and the role it could play in helping to bring more doctors to the region. Marshall said the expansion could help provide options for potential medical students. "It will go some distance toward providing additional – needed – physicians for Western New York and the Southern Tier," she said. "If anything, I believe this will provide more options for local applicants.”
Richard D. Blondell, MD, professor of family medicine and vice chair of addiction medicine, is interviewed about a letter in the journal Pain Medicine that urges U.S. policymakers to develop guidelines for tapering patients off opioids that are not “aggressive and unrealistic”. "Whether it's a fast taper or a slow taper, the big question is -- well, what do you do after that?" he said. "What we really need is better science, not more politics . . . In my experience, when you have global recommendations based on expert opinions and you try to apply those to individual patients at individual clinics there's a lot that gets lost in translation."
George Melvin Ellis Jr., a country doctor who earned his medical degree at UB and became UB’s largest donor, gave a total of more than $50 million to UB. The article recounts Ellis’ life as a doctor and quotes his UB classmate, Herbert E. Joyce, MD, as saying, “George always said that the greatest day of his life was the day he received his letter of acceptance to the UB medical school. He was without a doubt the most loyal to UB of anyone I have ever known.”
Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, showed that unusually high levels of a transcription factor called paired related homeobox protein 1 in human oligodendrocyte progenitor cells hinders their ability to respond to the loss of myelin and to transform into mature, myelin-producing oligodendryocytes, a finding that suggests a new potential way of treating multiple sclerosis. “We found that switching this gene on could cause problems in myelin repair by blocking the proliferation of the oligodendrocyte progenitor cell, the stem cell-like precursor that is responsible for all myelin regeneration in the adult brain,” Sim said.
Research by Brian Clemency, DO, associate professor of emergency medicine, found that opioid use patients who have been treated with naloxone for overdose and who meet certain clinical criteria can be safely discharged from the Emergency Department within an hour after treatment.
Richard M. Gronostajski, PhD, professor of biochemistry and director of the Genetics, Genomics and Bioinformatics graduate program, addresses ethical issues raised after a Chinese scientist claimed that he altered and edited the genes of twin baby girls to make them immune to the HIV virus using the new gene-altering tool CRISPR. “CRISPR has been revolutionary — it's been powerful,” he said. “It was anticipated that someone would eventually want to edit human beings. It’s a wake-up call.” 
BlueCross BlueShield has awarded $2.7 million in grant funding to nine health-based projects across Western New York, including $200,000 to the Jacobs School of Medicine and Biomedical Sciences for the expansion of emergency access to medication-assisted treatment for patients with opioid-use disorder as well as rapid referral to long-term treatment.
An article about why so many adults are reluctant to get a flu shot despite scientific evidence that shows the benefits of the vaccine interviews Thomas A. Russo, MD, professor of medicine and chief of infectious diseases. “Historically, adults do poorly with vaccines,” he said. “The other thing is that there is a fair amount of misinformation out there.” A related article about why people should get a flu shot every year features answers by local and national experts, including Russo. “Whenever you take any medication, there’s a small but finite chance you can have an adverse reaction to it,” he said, “but it’s very rare with the flu vaccine.”
Reports on a study using animal models conducted by researchers in the Department of Pharmacology and Toxicology and UB’s Clinical and Research Institute on Addictions that found that chronic use of Ritalin without the presence of symptoms of attention-deficit hyperactivity disorder resulted in neuroinflammation in brain regions associated with motivated behavior, quote Panayotis Thanos, PhD, senior research scientist. “One month after use was stopped, the inflammation and structural changes were still there,” he said. “This could result in long-term risks for young adults, as these areas of the brain also influence addiction and the ability to respond to changes in the environment.”
A feature story on a website covering news in diabetes, covers the work of Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, that has shown that drugs developed for Type 2 diabetes are also effective in treating patients with Type 1 diabetes. Dandona now is recruiting patients with Type 1 diabetes in a major Juvenile Diabetes Research Foundation-funded clinical trial to further test these drugs.
Nancy H. Nielsen, MD, PhD, senior associate dean for health policy, was quoted in an article about a plan by President Donald Trump that would gradually lower drug payment levels to levels based on international prices and set payment amounts for storing and handling drugs that are not tied to the drug’s cost. “This latest proposal is innovative, very good and long overdue. It’s a step in the right direction and it’s a smart model,” Nielsen said. “However, it’s going to face enormous opposition to come to fruition.”